Menu ×

HEALTHCARE & PHARMACEUTICAL

U.S. Ambulatory Surgical Centers Market Segmentation by Type (Hospital Affiliated, and Freestanding ASCs); by Specialty (Single Specialty, and Multi-Specialty Centers); by Ownership (Corporate-Physician, Hospital-Physician, Corporate-Hospital, Corporate Only, Physician Only, and Hospital Only); by Treatment – Demand Analysis & Opportunity Outlook 2019-2028

  • Text Size:

Extensive insights into the Growth of Ambulatory Surgery Centers Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

IN THE NEWS

  • December 10, 2020: Tenet Healthcare Corporation to acquire 45 ambulatory surgery centers (ASCs) from SurgCenter Development.

  • May 15, 2020: AMSURG, the ambulatory surgical center affiliated with Envision Healthcare, announced a new toolkit to guide ambulatory surgery centers to efficiently treat COVID-19 patients.

U.S. Ambulatory Surgical Centers (ASCs) Market Highlights Over 2019 - 2028

The U.S. ambulatory surgical centers market is estimated to garner a revenue of USD 33,024.13 million in 2028, up from USD 30,000 million in 2019 by growing at a CAGR of 6.9% over the forecast period, i.e., 2021 – 2028. The growth of the market can be primarily attributed to the growing healthcare expenditure in the region, along with the increase focus of the government to provide adequate medical facilities to remote locations in the country. According to the World Health Organization (WHO), as of 2018, 16.416 % of the GDP was spent on the healthcare sector in North America. Additionally, increasing overall healthcare expenditure in the United States backed by high share of aging population, increasing prevalence of diseases, and hike in the price of surgeries in hospitals, are some of the major factors boosting the market growth. Ambulatory surgical centers are equipped with advanced surgical equipment that is achieved through rapid technological advancements over the years. Further, high-quality medical services offered by the ASCs is further expected to drive their demand in the upcoming years.

U.S. Ambulatory Surgical Centers (ASCs) Market Graph

High occurrence of chronic diseases among older population is also estimated to fuel the demand for ambulatory surgical centers for the treatment of gastrointestinal, eye, musculoskeletal, and others diseases. In other statistics by the World Bank, in 2019, the share of population aged 65 years and above was recorded to be 16.21% of the total population in the U.S. Furthermore, increasing incidences of chronic diseases in the country is another major factor expected to promote the market growth. According to the data provided by the Centers for Disease Control and Prevention (CDC), currently, 6 in 10 adults in the country are suffering from a chronic disease. Additionally, 4 in 10 adults are said to have more than 2 chronic diseases. According to the other report by CDC, cardiovascular disease accounts for 1 death every 36 seconds in the United States. Additionally, an estimated 655,000 Americans die due to cardiovascular diseases each year. CLICK TO DOWNLOAD SAMPLE REPORT

U.S. Ambulatory Surgical Center Market Regional Synopsis

Regionally, the U.S. Ambulatory Surgical Center market is segmented into five major regions including West US, North East US, South East US, South West US, and Midwest US. The market in West US region is estimated to witness growth by a highest CAGR of 7.7% over the forecast period owing to the presence of a large number of ASCs in the states, such as California, and Washington, backed by the increasing prevalence of obesity, asthma, diabetes, hyper tension, and other fatal diseases amongst the individuals. According to the Ambulatory Surgical Centers Association, California has the highest number of Medicare-certified ambulatory surgical centers than any other U.S. state. In 2021, the state recorded 817 Medicare-certified ambulatory surgical centers. Moreover, increasing burden of heart patients, fueled by up-surge in lifestyle diseases in the region, is estimated to encourage the market growth. The market in the North East US is projected to garner the highest share of 26.09% along with a revenue of USD 8,616 million in 2028, up from USD 7,890 million in 2019. This can be attributed to the high geriatric population in the region, along with increasing demand for cost-effective and selective surgeries. According to the United States Census Bureau, the population aged 65 years and over in New Jersey recorded to be 16.6% in the year 2019. Moreover, in other statistics by the Ambulatory Surgical Centers Association, the number of Medicare-certified ambulatory surgical centers in the North East U.S. is on the rise, with 248 ambulatory surgical centers in New York, 259 centers in New Jersey, and 342 centers in Maryland.

Growth Drivers and Challenges Impacting the Growth of the U.S. Ambulatory Surgical Center Market

Growth Drivers

  • Growing Healthcare Expenditure
  • Increasing Demand for Cost Effective Surgeries
  • Rising Geriatric Population

Challenges

  • Declining Reimbursements
  • Presence of Advanced Hospitals and Positive Customer Response towards Hospitals

U.S. Ambulatory Surgical Center Market Segmentation Synopsis

The U.S. ambulatory surgical center market is divided by type into hospital affiliated, and freestanding ASCs, out of which, the freestanding ASCs segment held the largest share of 71.91% in the year 2019 and is estimated to generate a revenue of USD 24,508.2 million in 2028, up from USD 21, 572.1 million in 2019. This segment is also anticipated to grow with the highest CAGR of 7.3% during the forecast period, as the freestanding ASCs offer competitive pricing, and can be accessed by patients easily. On the basis of specialty, the market is bifurcated into single-specialty and multi-specialty centers, out of which, the single specialty centers segment is anticipated to hold the largest market share and further grow with the highest CAGR of 7.1% throughout the forecast period. The market is segmented based on ownership into corporate-physician, hospital-physician, corporate-hospital, corporate only, physician only, and hospital only, out of which, the physician-only segment is expected to attain the largest market revenue of USD 21677.2 million by the end of 2028. On the basis of treatment, the market is segmented into orthopedic surgeries, dental, ophthalmology surgeries, endoscopy, obstetrics/gynecology surgeries, cardiovascular surgeries, pain management, ENT surgeries, neurosurgery, gastrointestinal surgery, plastic surgery, and others, out of which, the gastrointestinal segment held the largest market share in 2019 and is further expected to reach USD 6762.4 million by the end of 2028.

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the U.S. ambulatory surgical center market that are included in our report are TH Medical, AMSURG Corp. (Envision Healthcare), Surgical Care Affiliates, SurgCenter, Regent Surgical Health, ASD Management, Ambulatory Surgical Centers of America, Physicians Endoscopy, LLC, Surgery Partners, and others.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
  • The report includes detailed company profiles of the major players dominating the market.
  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.

FREQUENTLY ASKED QUESTIONS

  1. Introduction
    1. Market Definition
    2. Market Segmentation
    3. Product Overview
  2. Assumptions And Acronyms
  3. Research Methodology
    1.          Research Process
    2. Primary Research
    3. Secondary Research
    4. Market Size Estimation
  4. Executive Summary- U.S. Ambulatory Surgical Centers Market
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Trends
    4. Opportunities
  6. Regulatory Landscape
  7. Patient Epidemiology Analysis
  8. Pricing Analysis
  9. Comparative Analysis of Payer System in U.S.
  10. Impact Of Covid-19 On the U.S. Ambulatory Surgical Centers Market
  11. Key Market Opportunities
  12. Analysis On the Number of ASCs in The United States
  13. Competitive Landscape
    1. Competitive Benchmarking of Key Players
    2. Company Profiles
      1. TH Medical
      2. AMSURG Corp. (Envision Healthcare)
      3. Surgical Care Affiliates
      4. SurgCenter
      5. Regent Surgical Health
      6. ASD Management
      7. Physicians Endoscopy, LLC
      8. Ambulatory Surgical Centers of America
      9. Surgery Partners
      10. Other Prominent Players
  14. U.S. Ambulatory Surgical Centers Market Outlook
    1. Market Value (USD Million)
    2. U.S. Ambulatory Surgical Centers Market Segmentation Analysis 2019-2028
      1. By Type
        1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
        2. Freestanding ASCs, 2019-2028F (USD Million)
      2. By Specialty
        1. Single Specialty Centers, 2019-2028F (USD Million)
        2. Multi-Specialty Centers, 2019-2028F (USD Million)
      3. By Ownership
        1. Corporate Physician, 2019-2028F (USD Million)
        2. Hospital Physician, 2019-2028F (USD Million)
        3. Corporate Hospital, 2019-2028F (USD Million)
        4. Corporate Only, 2019-2028F (USD Million)
        5. Physician Only, 2019-2028F (USD Million)
        6. Hospital Only, 2019-2028F (USD Million)
      4. By Treatment
        1. Orthopedic Surgeries, 2019-2028F (USD Million)
          1. Spinal Surgeries, 2019-2028F (USD Million)
          2. Knee Replacement Surgeries, 2019-2028F (USD Million)
          3. Joint Replacement Surgeries, 2019-2028F (USD Million)
          4. Ankle Repair, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        2. Dental, 2019-2028F (USD Million)
          1. Maxillofacial Surgeries, 2019-2028F (USD Million)
          2. Others, 2019-2028F (USD Million)
        3. Ophthalmology Surgeries, 2019-2028F (USD Million)
          1. Lasik, 2019-2028F (USD Million)
          2. Cataract, 2019-2028F (USD Million)
          3. Glaucoma Surgery, 2019-2028F (USD Million)
          4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
          5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
        4. Endoscopy, 2019-2028F (USD Million)
        5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
          1. Adhesiolysis, 2019-2028F (USD Million)
          2. Colposcopy, 2019-2028F (USD Million)
          3. Endometrial Ablation, 2019-2028F (USD Million)
          4. Cervical Biopsy, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        6. Cardiovascular Surgeries, 2019-2028F (USD Million)
          1. Aortic Surgery, 2019-2028F (USD Million)
          2. Heart Valve Repair, 2019-2028F (USD Million)
          3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
          4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        7. Pain Management, 2019-2028F (USD Million)
        8. Ent Surgeries, 2019-2028F (USD Million)
        9. Neurosurgery, 2019-2028F (USD Million)
        10. Gastrointestinal Surgery, 2019-2028F (USD Million)
        11. Plastic Surgery, 2019-2028F (USD Million)
        12. Others, 2019-2028F (USD Million)
  15. U.S. Ambulatory Surgical Centers Market Outlook, By Region
    1. West U.S. Ambulatory Surgical Centers Market Segmentation Analysis
    2. Market Value (USD Million)
      1. By Type
        1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
        2. Freestanding ASCs, 2019-2028F (USD Million)
      2. By Specialty
        1. Single Specialty Centers, 2019-2028F (USD Million)
        2. Multi-Specialty Centers, 2019-2028F (USD Million)
      3. By Ownership
        1. Corporate Physician, 2019-2028F (USD Million)
        2. Hospital Physician, 2019-2028F (USD Million)
        3. Corporate Hospital, 2019-2028F (USD Million)
        4. Corporate Only, 2019-2028F (USD Million)
        5. Physician Only, 2019-2028F (USD Million)
        6. Hospital Only, 2019-2028F (USD Million)
      4. By Treatment
        1. Orthopedic Surgeries, 2019-2028F (USD Million)
          1. Spinal Surgeries, 2019-2028F (USD Million)
          2. Knee Replacement Surgeries, 2019-2028F (USD Million)
          3. Joint Replacement Surgeries, 2019-2028F (USD Million)
          4. Ankle Repair, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        2. Dental, 2019-2028F (USD Million)
          1. Maxillofacial Surgeries, 2019-2028F (USD Million)
          2. Others, 2019-2028F (USD Million)
        3. Ophthalmology Surgeries, 2019-2028F (USD Million)
          1. Lasik, 2019-2028F (USD Million)
          2. Cataract, 2019-2028F (USD Million)
          3. Glaucoma Surgery, 2019-2028F (USD Million)
          4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
          5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
        4. Endoscopy, 2019-2028F (USD Million)
        5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
          1. Adhesiolysis, 2019-2028F (USD Million)
          2. Colposcopy, 2019-2028F (USD Million)
          3. Endometrial Ablation, 2019-2028F (USD Million)
          4. Cervical Biopsy, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        6. Cardiovascular Surgeries, 2019-2028F (USD Million)
          1. Aortic Surgery, 2019-2028F (USD Million)
          2. Heart Valve Repair, 2019-2028F (USD Million)
          3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
          4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        7. Pain Management, 2019-2028F (USD Million)
        8. Ent Surgeries, 2019-2028F (USD Million)
        9. Neurosurgery, 2019-2028F (USD Million)
        10. Gastrointestinal Surgery, 2019-2028F (USD Million)
        11. Plastic Surgery, 2019-2028F (USD Million)
        12. Others, 2019-2028F (USD Million)
    3. North East U.S. Ambulatory Surgical Centers Market Segmentation Analysis
    4. Market Value (USD Million)
      1. By Type
        1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
        2. Freestanding ASCs, 2019-2028F (USD Million)
      2. By Specialty
        1. Single Specialty Centers, 2019-2028F (USD Million)
        2. Multi-Specialty Centers, 2019-2028F (USD Million)
      3. By Ownership
        1. Corporate Physician, 2019-2028F (USD Million)
        2. Hospital Physician, 2019-2028F (USD Million)
        3. Corporate Hospital, 2019-2028F (USD Million)
        4. Corporate Only, 2019-2028F (USD Million)
        5. Physician Only, 2019-2028F (USD Million)
        6. Hospital Only, 2019-2028F (USD Million)
      4. By Treatment
        1. Orthopedic Surgeries, 2019-2028F (USD Million)
          1. Spinal Surgeries, 2019-2028F (USD Million)
          2. Knee Replacement Surgeries, 2019-2028F (USD Million)
          3. Joint Replacement Surgeries, 2019-2028F (USD Million)
          4. Ankle Repair, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        2. Dental, 2019-2028F (USD Million)
          1. Maxillofacial Surgeries, 2019-2028F (USD Million)
          2. Others, 2019-2028F (USD Million)
        3. Ophthalmology Surgeries, 2019-2028F (USD Million)
          1. Lasik, 2019-2028F (USD Million)
          2. Cataract, 2019-2028F (USD Million)
          3. Glaucoma Surgery, 2019-2028F (USD Million)
          4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
          5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
        4. Endoscopy, 2019-2028F (USD Million)
        5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
          1. Adhesiolysis, 2019-2028F (USD Million)
          2. Colposcopy, 2019-2028F (USD Million)
          3. Endometrial Ablation, 2019-2028F (USD Million)
          4. Cervical Biopsy, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        6. Cardiovascular Surgeries, 2019-2028F (USD Million)
          1. Aortic Surgery, 2019-2028F (USD Million)
          2. Heart Valve Repair, 2019-2028F (USD Million)
          3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
          4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        7. Pain Management, 2019-2028F (USD Million)
        8. Ent Surgeries, 2019-2028F (USD Million)
        9. Neurosurgery, 2019-2028F (USD Million)
        10. Gastrointestinal Surgery, 2019-2028F (USD Million)
        11. Plastic Surgery, 2019-2028F (USD Million)
        12. Others, 2019-2028F (USD Million)
    5. South East U.S. Ambulatory Surgical Centers Market Segmentation Analysis
    6. Market Value (USD Million)
      1. By Type
        1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
        2. Freestanding ASCs, 2019-2028F (USD Million)
      2. By Specialty
        1. Single Specialty Centers, 2019-2028F (USD Million)
        2. Multi-Specialty Centers, 2019-2028F (USD Million)
      3. By Ownership
        1. Corporate Physician, 2019-2028F (USD Million)
        2. Hospital Physician, 2019-2028F (USD Million)
        3. Corporate Hospital, 2019-2028F (USD Million)
        4. Corporate Only, 2019-2028F (USD Million)
        5. Physician Only, 2019-2028F (USD Million)
        6. Hospital Only, 2019-2028F (USD Million)
      4. By Treatment
        1. Orthopedic Surgeries, 2019-2028F (USD Million)
          1. Spinal Surgeries, 2019-2028F (USD Million)
          2. Knee Replacement Surgeries, 2019-2028F (USD Million)
          3. Joint Replacement Surgeries, 2019-2028F (USD Million)
          4. Ankle Repair, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        2. Dental, 2019-2028F (USD Million)
          1. Maxillofacial Surgeries, 2019-2028F (USD Million)
          2. Others, 2019-2028F (USD Million)
        3. Ophthalmology Surgeries, 2019-2028F (USD Million)
          1. Lasik, 2019-2028F (USD Million)
          2. Cataract, 2019-2028F (USD Million)
          3. Glaucoma Surgery, 2019-2028F (USD Million)
          4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
          5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
        4. Endoscopy, 2019-2028F (USD Million)
        5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
          1. Adhesiolysis, 2019-2028F (USD Million)
          2. Colposcopy, 2019-2028F (USD Million)
          3. Endometrial Ablation, 2019-2028F (USD Million)
          4. Cervical Biopsy, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        6. Cardiovascular Surgeries, 2019-2028F (USD Million)
          1. Aortic Surgery, 2019-2028F (USD Million)
          2. Heart Valve Repair, 2019-2028F (USD Million)
          3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
          4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        7. Pain Management, 2019-2028F (USD Million)
        8. Ent Surgeries, 2019-2028F (USD Million)
        9. Neurosurgery, 2019-2028F (USD Million)
        10. Gastrointestinal Surgery, 2019-2028F (USD Million)
        11. Plastic Surgery, 2019-2028F (USD Million)
        12. Others, 2019-2028F (USD Million)
    7. South West U.S. Ambulatory Surgical Centers Market Segmentation Analysis
    8. Market Value (USD Million)
      1. By Type
        1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
        2. Freestanding ASCs, 2019-2028F (USD Million)
      2. By Specialty
        1. Single Specialty Centers, 2019-2028F (USD Million)
        2. Multi-Specialty Centers, 2019-2028F (USD Million)
      3. By Ownership
        1. Corporate Physician, 2019-2028F (USD Million)
        2. Hospital Physician, 2019-2028F (USD Million)
        3. Corporate Hospital, 2019-2028F (USD Million)
        4. Corporate Only, 2019-2028F (USD Million)
        5. Physician Only, 2019-2028F (USD Million)
        6. Hospital Only, 2019-2028F (USD Million)
      4. By Treatment
        1. Orthopedic Surgeries, 2019-2028F (USD Million)
          1. Spinal Surgeries, 2019-2028F (USD Million)
          2. Knee Replacement Surgeries, 2019-2028F (USD Million)
          3. Joint Replacement Surgeries, 2019-2028F (USD Million)
          4. Ankle Repair, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        2. Dental, 2019-2028F (USD Million)
          1. Maxillofacial Surgeries, 2019-2028F (USD Million)
          2. Others, 2019-2028F (USD Million)
        3. Ophthalmology Surgeries, 2019-2028F (USD Million)
          1. Lasik, 2019-2028F (USD Million)
          2. Cataract, 2019-2028F (USD Million)
          3. Glaucoma Surgery, 2019-2028F (USD Million)
          4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
          5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
        4. Endoscopy, 2019-2028F (USD Million)
        5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
          1. Adhesiolysis, 2019-2028F (USD Million)
          2. Colposcopy, 2019-2028F (USD Million)
          3. Endometrial Ablation, 2019-2028F (USD Million)
          4. Cervical Biopsy, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        6. Cardiovascular Surgeries, 2019-2028F (USD Million)
          1. Aortic Surgery, 2019-2028F (USD Million)
          2. Heart Valve Repair, 2019-2028F (USD Million)
          3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
          4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        7. Pain Management, 2019-2028F (USD Million)
        8. Ent Surgeries, 2019-2028F (USD Million)
        9. Neurosurgery, 2019-2028F (USD Million)
        10. Gastrointestinal Surgery, 2019-2028F (USD Million)
        11. Plastic Surgery, 2019-2028F (USD Million)
        12. Others, 2019-2028F (USD Million)
    9. North East U.S. Ambulatory Surgical Centers Market Segmentation Analysis
    10. Market Value (USD Million)
      1. By Type
        1. Hospital Affiliated ASCs, 2019-2028F (USD Million)
        2. Freestanding ASCs, 2019-2028F (USD Million)
      2. By Specialty
        1. Single Specialty Centers, 2019-2028F (USD Million)
        2. Multi-Specialty Centers, 2019-2028F (USD Million)
      3. By Ownership
        1. Corporate Physician, 2019-2028F (USD Million)
        2. Hospital Physician, 2019-2028F (USD Million)
        3. Corporate Hospital, 2019-2028F (USD Million)
        4. Corporate Only, 2019-2028F (USD Million)
        5. Physician Only, 2019-2028F (USD Million)
        6. Hospital Only, 2019-2028F (USD Million)
      4. By Treatment
        1. Orthopedic Surgeries, 2019-2028F (USD Million)
          1. Spinal Surgeries, 2019-2028F (USD Million)
          2. Knee Replacement Surgeries, 2019-2028F (USD Million)
          3. Joint Replacement Surgeries, 2019-2028F (USD Million)
          4. Ankle Repair, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        2. Dental, 2019-2028F (USD Million)
          1. Maxillofacial Surgeries, 2019-2028F (USD Million)
          2. Others, 2019-2028F (USD Million)
        3. Ophthalmology Surgeries, 2019-2028F (USD Million)
          1. Lasik, 2019-2028F (USD Million)
          2. Cataract, 2019-2028F (USD Million)
          3. Glaucoma Surgery, 2019-2028F (USD Million)
          4. Diabetic Retinopathy Surgery, 2019-2028F (USD Million)
          5. Others (Retinal, Cornea, Strabismus), 2019-2028F (USD Million)
        4. Endoscopy, 2019-2028F (USD Million)
        5. Obstetrics/Gynecology Surgeries, 2019-2028F (USD Million)
          1. Adhesiolysis, 2019-2028F (USD Million)
          2. Colposcopy, 2019-2028F (USD Million)
          3. Endometrial Ablation, 2019-2028F (USD Million)
          4. Cervical Biopsy, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        6. Cardiovascular Surgeries, 2019-2028F (USD Million)
          1. Aortic Surgery, 2019-2028F (USD Million)
          2. Heart Valve Repair, 2019-2028F (USD Million)
          3. Coronary Artery Bypass Surgery, 2019-2028F (USD Million)
          4. Minimally Invasive Cardiac Surgery, 2019-2028F (USD Million)
          5. Others, 2019-2028F (USD Million)
        7. Pain Management, 2019-2028F (USD Million)
        8. Ent Surgeries, 2019-2028F (USD Million)
        9. Neurosurgery, 2019-2028F (USD Million)
        10. Gastrointestinal Surgery, 2019-2028F (USD Million)
        11. Plastic Surgery, 2019-2028F (USD Million)
        12. Others, 2019-2028F (USD Million)

Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved